Stay updated on Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial page.

Latest updates to the Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial page
- CheckyesterdayChange DetectedThe site footer’s revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check8 days agoChange DetectedA notice was added announcing changes to NIH website terminology, including the use of “Super Intelligence” in place of “Artificial Intelligence” during a transition period.SummaryDifference0.7%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check22 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check43 days agoChange DetectedAn updated revision entry v3.7.0 has been added to the history, and the previous v3.6.6 entry was removed. This reflects changes to the record's version history rather than to the study data or page functionality.SummaryDifference0.1%

- Check64 days agoChange DetectedThe study record history now shows a new revision entry labeled v3.6.6. The previous v3.6.5 entry is removed, updating the version history.SummaryDifference0.1%

Stay in the know with updates to Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial page.